4//SEC Filing
Skolnick Phil 4
Accession 0001385508-23-000020
CIK 0001385508other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:11 PM ET
Size
4.9 KB
Accession
0001385508-23-000020
Insider Transaction Report
Form 4
Skolnick Phil
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-01-09$20.20/sh−369$7,454→ 22,028 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001358116
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:11 PM ET
- Size
- 4.9 KB